We noticed you’re blocking ads

Thanks for visiting CRSToday. Our advertisers are important supporters of this site, and content cannot be accessed if ad-blocking software is activated.

In order to avoid adverse performance issues with this site, please white list https://crstoday.com in your ad blocker then refresh this page.

Need help? Click here for instructions.

The Future's So Bright, I Gotta Wear Shades

The Literature

Inside Eyetube.net | June 2017

This Month on Eyetube

Triumvirate Technique: Modified PAL With IOL Scaffold and Glued IOL

By Priya Narang, MS

Crystalens and iStent With Stellaris Elite

By Mitchell Shultz, MD

Zepto Cataract Surgery and Premium IOL Implantation in Challenging Cases

By Suresh K. Pandey, MD, and Vidushi Sharma, MD

Full Surgical Case Featuring the Intrepid Transformer I/A System

By John Berdahl, MD

NEXT IN THIS ISSUE

We noticed you’re blocking ads

Cataract & Refractive
Surgery Today

Inside Eyetube.net | June 2017

This Month on Eyetube

Triumvirate Technique: Modified PAL With IOL Scaffold and Glued IOL

Crystalens and iStent With Stellaris Elite

Zepto Cataract Surgery and Premium IOL Implantation in Challenging Cases

Full Surgical Case Featuring the Intrepid Transformer I/A System

X

You are now leaving the DURYSTA™ (bimatoprost implant) digital supplement. This link will take you to a site maintained by Bryn Mawr Communications, LLC, who is solely responsible for its content.

We noticed you’re blocking ads

Triumvirate Technique: Modified PAL With IOL Scaffold and Glued IOL

Crystalens and iStent With Stellaris Elite

Zepto Cataract Surgery and Premium IOL Implantation in Challenging Cases

Full Surgical Case Featuring the Intrepid Transformer I/A System

Advertisement - Issue Continues Below

End of Advertisement - Issue Continues Below

Or subscribe on your tablet:

X

Complete a 3-minute survey to help CRST understand your practice patterns during the COVID-19 pandemic and be entered for the chance to win one of 10 $50 Amazon gift cards.

X

You are now leaving the DURYSTA™ (bimatoprost implant) digital supplement. This link will take you to a site maintained by Bryn Mawr Communications, LLC, who is solely responsible for its content.